A study by Awada et al. showed that the presence of ASXL1 mutations in Philadelphia-negative MPNs is considered to be a risk factor for bleeding; however, in that study, no CNL patients were studied [53]. Here, ASXL1 is linked to chronic neutrophilic leukemia.